Fleur M. et al. developed DCLK1-IN-1, the first in vivo-compatible and selective chemical probe of the DCLK1 kinase domain, which showed anti-cancer activity by regulating cell motility associated proteins and signaling in PDAC PDOs [99]. Here, DCLK1 is linked to cancer.